US Data Center Construction Boom by the Numbers: $700 Billion in AI Infrastructure Spending Explained

Data center construction and AI infrastructure spending in the United States are on pace to hit approximately $700 billion in 2026, an 81% increase over 2025, making this the largest single-category construction boom in the country. Data center construction starts totaled just $14.9 billion in 2023. By 2025, that figure had exploded to $77.7 billion, a 190% year-over-year increase. To put the scale of 2026 spending in perspective, the entire US Interstate Highway System cost roughly $530 billion in today’s dollars and took decades to build. The data center industry is now spending more than that in a single year.

How Fast Is Data Center Construction Growing in 2026?

The pace of growth in 2026 has genuinely surprised even industry veterans. Year-to-date spending through April reached $49.5 billion, compared to just $13.6 billion over the same period the prior year, nearly four times the pace. Q1 2026 alone saw $44.7 billion in data center investment, up 28% year over year. January 2026 brought a record $25.2 billion in new groundbreakings in a single month. A rolling $9.8 billion monthly moving average through April 2026, more than 300% above year-ago levels, suggests this is a sustained structural shift in how capital is being allocated across the American construction industry, not a short-term spike tied to one or two megaprojects.

The scale of individual commitments underscores the point. Hyperscale technology companies including Microsoft, Amazon, Google, and Meta have collectively committed over $500 billion to AI infrastructure this year. That figure builds directly on what we covered in Amazon’s recent earnings report, where AWS alone raised its own capital expenditure guidance to approximately $220 billion for the year. Vantage committed $25 billion to a single Texas campus, and Meta broke ground on a 900 megawatt facility in Wisconsin specifically to leverage nearby hydropower access, a facility that will also require exactly the kind of specialized bond financing we detailed in our recent coverage of BlackRock’s data center bond offering for Meta.

Which States Are Leading the Data Center Construction Boom?

The geography of this boom has shifted quickly. Virginia led all states with $15.3 billion in data center construction starts in 2025, followed closely by Louisiana at $15.0 billion, Mississippi at $13.9 billion, and Texas at $13.4 billion. States that once competed aggressively over auto manufacturing plants are now competing over server farms, offering tax incentives, expedited permitting, and utility rate structures designed specifically to attract hyperscale campuses.

Why Data Center Demand Shows No Sign of Slowing

Global data center occupancy has reached a record 97%, a figure that reflects genuine capacity scarcity rather than speculative overbuilding. Nearly 100 gigawatts of new data center capacity is anticipated to come online globally between 2026 and 2030, effectively doubling total global capacity in five years. Roughly $7 trillion in global capital expenditures on data center infrastructure is projected by 2030, with more than 40% of that spending expected to occur in the United States specifically.

Construction costs have climbed alongside demand. Standard data center builds now cost between $10 million and $12 million per megawatt of capacity, while AI-ready facilities designed for the density and cooling requirements of advanced chip clusters run $20 million or more per megawatt. That capital intensity is precisely the dynamic we explored in our coverage of Oracle’s debt-funded AI buildout, where the gap between committed spending and near-term returns became a genuine investor concern.

Small Cap Data Center Stocks: Where the Opportunity Lies in the Supply Chain

For investors tracking small and microcap companies, this buildout represents far more than a story about a handful of hyperscale technology giants. Roughly 60% of total data center investment flows into the technology and hardware required to run these facilities, but the remaining 40% is split between land and building construction and, critically, power generation and cooling infrastructure, which alone accounts for approximately 25% of total spend.

That power and cooling category is where the opportunity for smaller companies becomes most direct. Electrical contractors, specialized cooling system providers, power management component manufacturers, backup generation equipment makers, and grid infrastructure companies are all seeing sustained demand growth from a construction category that contractors themselves rank as the single strongest growth segment in the industry, with 65% of contractors surveyed expecting increased data center spending in 2026, the highest expectation across every category of construction tracked.

With 76 individual data center projects totaling more than $88 billion scheduled to begin construction in just the next six months, and roughly 2,788 additional facilities already announced or under construction across the country, the supply chain feeding this buildout is likely to remain one of the more durable growth stories in the American economy well into the next decade.

Summit Midstream Corp (SMC) – Second Quarter Results Exceed Expectations


Wednesday, August 12, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Second Quarter FY 2026 Financial Results. Summit Midstream generated $155.0 million of revenue, up 10.6% from the prior year quarter, and reported net income attributable to Summit Midstream Corp. of $1.6 million, or $0.11 per share, compared with a net loss of $8.0 million, or $(0.66) per share, during the prior year period. Adj. EBITDA amounted to $60.7 million compared to $61.1 million during the prior year period, as stronger Rockies and Permian performance was offset by weaker Mid-Con and Piceance segment results. We had forecast revenue of $144.4 million and adj. EBITDA of $59.7 million. Distributable cash flow increased to $36.8 million from $32.4 million, and free cash flow increased modestly to $9.4 million compared to $9.2 million during the second quarter of 2025. Sequentially, SMC’s second quarter results demonstrated meaningful improvement, supported by stronger producer activity and higher throughput across much of the portfolio.

Guidance Narrowed. Management narrowed its FY 2026 guidance range for adj. EBITDA to $235 million to $255 million from $225 million to $265 million, and increased capital expenditure guidance to $100 million to $120 million from $85 million to $105 million. The increased capital budget is primarily tied to approximately 30 additional Williston Basin well connections and incremental investment in the Double E pipeline, while accelerating producer activity, additional firm transportation agreements, and a potential Double E compression expansion support the longer-term growth outlook.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Snail (SNAL) – Setting the Stage for a Stronger Second Half


Wednesday, August 12, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

George Proost, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Q2 Results Were Soft, Ahead of a Busier Second Half. Second quarter revenue declined to $19.7 million from $22.2 million, while bookings decreased to $21.8 million from $27.1 million, and EBITDA was a $3.0 million loss versus a $2.4 million loss in the prior-year period. Despite the softer quarter, first-half revenue increased 11.1% to $47.0 million, while EBITDA improved to a loss of $0.6 million from a loss of $5.8 million. 

Second-Half Setup Improves Following Major ARK Content Releases. Shortly after quarter-end, Snail released Tides of FortuneGenesis Part 1 Ascended, and Dragontopia, establishing a more active content cadence for the remainder of 2026. Management believes the broader ARK slate through 2027 provides a strong foundation for improved monetization and revenue visibility. 


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Nutriband (NTRB) – Looking Forward To Product Milestones In The Second Half FY2026


Wednesday, August 12, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

AVERSA Fentanyl Continues To Make Progress. Nutriband has been working in several areas to advance AVERSA Fentanyl toward the market. These include preparations for the registration trial, manufacturing, and commercialization. We continue to see AVERSA Fentanyl as an important product that could make fentanyl a safe, abuse-resistant option for pain relief.

Clinical Trial Expected Later In FY2026. The AVERSA Fentanyl application for FDA approval requires only a single clinical trial providing data to show that Fentanyl abusers prefer generic patches to the abuse-deterrent AVERSA technology. We expect this to be a short trial with a relatively small number of patients. Manufacturing clinical supplies is progressing, with the trial expected to begin around late Fall 2026.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Conduent (CNDT) – Positioned for a Stronger Second Half


Wednesday, August 12, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

George Proost, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Q2 results reflect ongoing transformation. Continuing operations revenue declined 11.9% to $531 million, while adjusted EBITDA was $16 million, or a 3.0% margin. Commercial remained pressured by contract losses and lower volumes, while Government results reflected the timing of Medicaid implementation activity.

Guidance supports a stronger second half. Management established 2026 continuing operations guidance of $2.15-$2.25 billion of revenue and $140-$170 million of adjusted EBITDA, implying a roughly 7% EBITDA margin at the midpoint. Our estimates of $2.21 billion and $157 million, respectively, are modestly above the midpoint of guidance.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

July CPI Report Preview: Inflation Expected to Ease to 3.4% as Fed Weighs a September Rate Hike

What the July CPI Report Is Expected to Show

New inflation data due out Wednesday is expected to show consumer prices rising 3.4% year over year in July, according to economists surveyed by Bloomberg, a slight improvement from June’s 3.5% annual increase. On a monthly basis, economists expect prices to rise just 0.1% from June, when the Consumer Price Index posted a surprise 0.4% monthly decline.

Core inflation, which strips out volatile food and energy costs and is the measure the Federal Reserve watches most closely, is expected to come in at 2.5% year over year and 0.2% month over month. Both figures would represent continued, if gradual, progress toward the Fed’s 2% inflation target, even as the overall trajectory remains well above where policymakers want it.

Why Energy Prices Complicate the Inflation Picture

The July reading arrives against a genuinely unusual backdrop. Energy prices rose over the course of the month after the ceasefire between the United States and Iran broke down and oil prices moved higher in response. Despite that renewed volatility, gasoline prices at the pump remained slightly lower on average in July than they were in June, according to data from the US Energy Information Administration.

That divergence between crude oil price movement and retail gasoline prices reflects the lag between wholesale energy costs and what consumers actually pay at the pump, and it is one reason economists still expect the headline CPI figure to show only modest sequential price growth despite the renewed geopolitical volatility.

What a Hot Inflation Print Would Mean for the September Fed Meeting

The stakes attached to Wednesday’s release extend well beyond the number itself. A hotter-than-expected inflation reading would likely push a divided Federal Reserve toward raising interest rates at its September meeting, even as other parts of the economy show signs of cooling. That tension is precisely what makes this month’s data release so consequential. The Fed is currently navigating contradictory signals: inflation readings remain well above target, while the labor market has shown genuine weakness, with the July jobs report showing the US economy shed 23,000 jobs, far short of what economists had expected.

As of this week, traders are pricing in roughly 50-50 odds of a 25 basis point rate hike at the Fed’s September meeting, according to CME FedWatch data, reflecting just how finely balanced the policy decision has become.

What the July CPI Report Means for Small Cap Investors

For companies operating below the $2 billion market cap threshold, Wednesday’s inflation data carries direct implications for the cost of capital heading into the fall. Small and microcap companies typically carry more variable-rate debt than their large cap counterparts, making them more sensitive to shifts in rate expectations than almost any other segment of the market.

A cooler-than-expected CPI print would strengthen the case for the Fed to hold steady in September, providing meaningful relief for smaller, more leveraged companies. A hotter print, particularly one showing energy-driven price pressure spreading into core categories, would sharpen the odds of a rate hike and extend the higher-cost-of-capital environment that has weighed on small cap valuations throughout much of this year. Either way, Wednesday’s release is one of the most consequential data points small cap investors will see before the Fed’s September decision.

Inside Archer’s Boeing Acquisition: Drones, Defense, and Autonomous Flight

Archer Aviation (Nasdaq: ACHR) and Joby Aviation (NYSE: JOBY) are both racing toward the same electric air taxi future, but their second quarter results, reported within days of each other, reveal two fundamentally different strategies for surviving the long and expensive road to commercial service. Joby posted stronger near-term revenue. Archer made a move that pulls it directly into the defense and unmanned systems market.

Joby reported $38.6 million in second quarter revenue, up from $24.6 million the prior quarter, and raised its full-year 2026 revenue forecast to a range of $115 million to $125 million. Much of that growth came from Blade, Joby’s helicopter charter business, which generated $36.2 million in revenue with seat sales up more than 50% year over year. The company still posted a net loss of $245.4 million for the quarter.

Archer reported just $5 million in revenue, though that figure was up 213% from the prior quarter and came in above estimates. Operating expenses reached $284.2 million, and the company posted a net loss of $263.2 million. Archer holds approximately $1.56 billion in cash and investments, compared to roughly $2.3 billion for Joby.

The more consequential development from Archer’s quarter had little to do with air taxis directly. Archer agreed to acquire three aerospace and defense businesses from Boeing in exchange for Boeing shares, a deal that immediately broadens Archer’s business well beyond passenger eVTOL aircraft. The acquired businesses include Wisk Aero, which develops autonomous electric vertical takeoff and landing aircraft, SkyGrid, which builds technology to safely manage autonomous aircraft operations, and Insitu, a maker of unmanned aircraft used primarily for surveillance and defense applications.

Combined, these three businesses bring nearly 2 million flight hours of real-world data to Archer, along with technology feeding directly into Archer’s ZEE AI platform, which integrates light, air-traffic, weather, terrain, and aircraft data to improve flight safety and efficiency. In effect, Archer is transforming from a single-product air taxi company into a broader aerospace, defense, and autonomy platform, with unmanned aircraft and drone technology now sitting at the center of that expansion.

Why the Drone Angle Matters Right Now

This deal lands at a moment when military and commercial demand for unmanned aircraft systems is accelerating sharply, driven by ongoing conflicts that have pushed defense procurement toward drone technology at a pace not seen in years. Insitu’s surveillance and defense-focused unmanned aircraft slot directly into that demand environment, giving Archer exposure to a growth market that operates on an entirely different timeline and revenue model than commercial passenger certification.

That broader drone sector tailwind extends well beyond large defense primes and newly diversified companies like Archer. Smaller, specialized defense technology companies are positioned to benefit from the same military modernization push, including names like T3 Defense, which operates in the unmanned systems and defense technology space that is seeing exactly this kind of accelerated government and commercial investment.

Despite their diverging strategies, both Archer and Joby remain a considerable distance from full FAA commercial certification for piloted eVTOL passenger service. Archer’s Midnight aircraft has completed Phase 3 of the FAA’s four-step certification process, while Joby currently has five aircraft flying and 12 more in production, aided by a manufacturing partnership with Toyota. Both companies plan to begin limited eIPP pilot flights in Texas later this year as a bridge toward full commercial operations.

For investors tracking the broader unmanned aircraft and defense technology space, Archer’s pivot illustrates a theme playing out across the sector this year. Companies with exposure to drone and autonomous flight technology, whether through diversification like Archer’s Boeing deal or through smaller, more focused defense technology platforms, are tapping into a genuinely different and arguably more near-term demand environment than the still-unproven commercial air taxi market both companies are ultimately chasing.

The Beachbody Company (BODI) – Finding Its Footing in Retail


Tuesday, August 11, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Another profitable quarter. Q2 revenue of $49.6 million exceeded the midpoint of guidance, while adjusted EBITDA of $6.7 million exceeded the high end and marked the company’s 11th consecutive quarter of positive adjusted EBITDA. While revenues were in line, the company exceeded our $4.5 million adj. EBITDA estimate. 

Retail traction encouraging. Shakeology distribution expanded to 131 Sprouts stores, with early reorders supporting favorable sell-through, while the company recently launched in 481 Vitamin Shoppe locations. Approximately 12 additional retail decisions are expected between mid-September and late November.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Summit Midstream Corp (SMC) – Improving Growth Outlook and Operational Momentum


Tuesday, August 11, 2026

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Second Quarter FY 2026 Financial Results. Summit Midstream generated $155.0 million of revenue, up 10.6% from the prior-year quarter, and reported net income attributable to Summit Midstream Corp. of $1.6 million, or $0.11 per share, compared with a net loss of $8.0 million, or $(0.66) per share, during the prior year period. Adj. EBITDA amounted to $60.7 million compared to $61.1 million during the prior year period, as stronger Rockies and Permian performance was offset by weaker Mid-Con and Piceance segment results. We had forecast revenue of $144.4 million and adj. EBITDA of $59.7 million. Distributable cash flow increased to $36.8 million from $32.4 million, and free cash flow increased modestly to $9.4 million compared to $9.2 million during the second quarter of 2025. Sequentially, SMC’s second quarter results demonstrated meaningful improvement, supported by stronger producer activity and higher throughput volume across much of the portfolio.  

Guidance Narrowed. Management narrowed its FY 2026 guidance range for adj. EBITDA to $235 million to $255 million from $225 million to $265 million, and increased capital expenditure guidance to $100 million to $120 million from $85 million to $105 million. The increased capital budget is primarily tied to approximately 30 additional Williston Basin well connections and incremental investment in the Double E pipeline, while accelerating producer activity, additional firm transportation agreements, and a potential Double E compression expansion support the longer-term growth outlook.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

NeuroSense Therapeutics Ltd. (NRSN) – NeuroSense Announces Target Date For Canadian PrimeC Approval Application


Tuesday, August 11, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Pre-Application Process Has Been Completed. NeuroSense announced that it has completed Pre-NDS meetings with Health Canada and plans to submit a New Drug Submission (NDS) for PrimeC in its ALS indication. These meetings focused on whether the data could support approval and the submission requirements. The target date is December 2026. We see this as good news that is consistent with our expectations.

We View The Canadian NDS Process As An Important Milestone For PrimeC. The NDS application will include the Phase 2b PARADIGM trial data, with additional preclinical and supporting data. The primary endpoint in the trial showed a reduction in TDP-43 (TAR DNA-binding Protein 43, a protein that drives ALS progression and deterioration). The data also showed increased median survival, improved functional assessments, biomarkers showing slower disease progression, as well as safety and tolerability. Approval would be based on Health Canada’s analysis of these data.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

NanoViricides (NNVC) – NanoViricides Receives Regulatory Approval To Begin Phase 2 For Ebola In Africa


Tuesday, August 11, 2026

Robert LeBoyer, Senior Vice President, Equity Research Analyst, Biotechnology, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Regulatory Approval Allows the Phase 2 Trial for NV-387 To Begin. NanoViricides has received approval to proceed with its Phase 2 trial of NV-387 for the treatment of Ebola in the Democratic Republic of Congo (DRC). We expect the Ebola trial to be followed by a separate Phase 2 trial in Mpox, also to be conducted in the DRC. This is consistent with our expected time frame for the trials.

Previous Preparations Should Allow Treatment To Start Soon. NanoViricides has completed delivery of clinical supplies of NV-387 oral solid formulation (gummies) for treatment of the trial. The trial will be conducted by OM Sai Clinical Research, a contract research organization (CRO) based in India. The CRO has assembled a clinical team with a Principal Investigator, local clinicians, and a university in the region to support the trial. The approval by ACOREP (Autorité Congolaise de Réglementation Pharmaceutique, the Congolese Pharmaceutical Regulatory Authority) should allow the trial to start patient treatment shortly.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

CoreCivic, Inc. (CXW) – $500 Million Accelerated Share Repurchase


Tuesday, August 11, 2026

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

ASR. CoreCivic has decided how to use a portion of the proceeds from the facilities sale, and it’s a $500 million Accelerated Share Repurchase program. The Company already used over $600 million of net proceeds to reduce debt, and increased share repurchases were a logical use of additional funds, in our opinion. Upon completion of the ASR Agreement, the Company anticipates that approximately $255.8 million of share repurchase authorization will remain available.

Details. The Company made a payment of $500 million to a financial institution on August 10, 2026, and expects to receive an initial delivery of approximately 12.4 million shares of CXW common stock (about 12.5% of the outstanding) from the financial institution, pursuant to the ASR Agreement. Based on Friday’s closing price, the initial 12.4 million shares would have used approximately $400 million of the $500 million.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Conduent (CNDT) – Execution Takes Center Stage


Tuesday, August 11, 2026

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

George Proost, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Execution continues to improve. Management reiterated that second quarter results were in line with expectations while highlighting meaningful progress across its five strategic priorities, including cost reduction, financial discipline, portfolio optimization, and pipeline conversion. Six months into the transformation, management believes the company is beginning to see tangible operational improvements.

Transportation exit strengthens the financial profile. The announced sales of the Transit and Tolling businesses are expected to generate approximately $234 million of gross proceeds, reduce off-balance-sheet obligations by roughly 80%, lower capital requirements, and provide significant flexibility to reduce debt while sharpening management’s focus on its core businesses.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.